Financial Performance - The Group's revenue for the six months ended September 30, 2025, was approximately HK$160.1 million, a decrease of approximately HK$40.0 million or 20.0% compared to HK$200.1 million for the same period in 2024[9] - Loss attributable to the owners of the Company was approximately HK$0.3 million for the six months ended September 30, 2025, compared to a loss of HK$0.6 million for the same period in 2024[9] - The Company reported a profit before tax of HK$0.96 million for the six months ended September 30, 2025, compared to a profit of HK$1.76 million for the same period in 2024[10] - The total comprehensive loss for the period ended September 30, 2025, was HK$189,000, compared to a total comprehensive loss of HK$156,000 for the same period in 2024, indicating a worsening of approximately 21.1%[13] - The Group reported a loss attributable to ordinary equity holders of HK$335,000 for the six months ended September 30, 2025, an improvement from a loss of HK$630,000 in the same period of 2024[42] Assets and Liabilities - Total non-current assets decreased from HK$156.3 million as of March 31, 2025, to HK$132.1 million as of September 30, 2025[11] - Current assets increased from HK$314.99 million as of March 31, 2025, to HK$322.59 million as of September 30, 2025[11] - The net current assets increased from HK$51.14 million as of March 31, 2025, to HK$59.92 million as of September 30, 2025[11] - As of September 30, 2025, total non-current liabilities decreased to HK$44,619,000 from HK$59,866,000 as of March 31, 2025, representing a reduction of approximately 25.5%[12] - The net assets as of September 30, 2025, were HK$147,373,000, slightly down from HK$147,562,000 as of March 31, 2025, indicating a decrease of about 0.13%[12] Revenue Breakdown - Revenue from treatment services was HK$141,592,000, down 17% from HK$170,722,000 in the previous year[33] - Revenue from skincare products decreased by 37% to HK$18,477,000 from HK$29,336,000[33] - Total revenue for the six months ended September 30, 2025, was HK$160,080,000, a decrease of 20% compared to HK$200,076,000 for the same period in 2024[33] Cash Flow and Liquidity - For the six months ended September 30, 2025, the net cash flows from operating activities were HK$31,763,000, a decrease of 13.4% compared to HK$36,601,000 for the same period in 2024[14] - Cash and cash equivalents at the end of the period were HK$81,923,000, down from HK$89,092,000 at the end of the same period in 2024, reflecting a decrease of about 8.1%[14] - Cash and cash equivalents as of September 30, 2025, were approximately HK$186.6 million, indicating a stable financial position[94] Operational Efficiency - Staff costs decreased by approximately HK$12.1 million or 16.3%, from approximately HK$74.2 million in the previous period to approximately HK$62.1 million[79] - Property rentals and related expenses decreased by approximately HK$4.1 million or 14.2%, from approximately HK$28.9 million in the previous period to approximately HK$24.8 million[80] - Other expenses, net decreased by approximately HK$12.4 million or 24.1%, from approximately HK$51.4 million in the previous period to approximately HK$39.0 million[82] Corporate Governance - The Company has complied with all applicable code provisions of the Corporate Governance Code during the six months ended 30 September 2025, except for the separation of the roles of chairman and chief executive officer[148] - The independent non-executive Directors have reviewed the implementation of the deed of non-competition and confirmed compliance by the Controlling Shareholders[140] - The Company has established an audit committee consisting of three independent non-executive Directors to oversee financial reporting[156] Market and Strategic Outlook - The Group aims to maintain profitability and core competitiveness through stable and prudent operating strategies amidst a relatively uncertain global economy[73] - The skincare brand XOVĒ is developing its e-commerce channels and sales platform in Mainland China while maintaining physical shops in four high-end shopping malls in Hong Kong[72] - The wellness beauty brand VITAE operates two treatment centres in Hong Kong's core business districts, focusing on creating a balanced aesthetic experience[71] Shareholder Information - As of September 30, 2025, Ms. LAI Ka Yee Gigi holds a long position of 275,000,000 shares, representing 68.75% of the Company's issued share capital[120] - Sunny Bright holds 275,000,000 shares of the Company, representing 68.75% of the issued share capital[127] - Meitu, Inc. is a beneficial owner of 20,000,000 shares, accounting for 5% of the issued share capital[127]
卓珈控股(01827) - 2026 - 中期财报